chr12-52487848-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_005554.4(KRT6A):​c.1567G>A​(p.Val523Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000764 in 1,613,996 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V523F) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0014 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00070 ( 1 hom. )

Consequence

KRT6A
NM_005554.4 missense

Scores

1
18

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -2.31
Variant links:
Genes affected
KRT6A (HGNC:6443): (keratin 6A) The protein encoded by this gene is a member of the keratin gene family. The type II cytokeratins consist of basic or neutral proteins which are arranged in pairs of heterotypic keratin chains coexpressed during differentiation of simple and stratified epithelial tissues. As many as six of this type II cytokeratin (KRT6) have been identified; the multiplicity of the genes is attributed to successive gene duplication events. The genes are expressed with family members KRT16 and/or KRT17 in the filiform papillae of the tongue, the stratified epithelial lining of oral mucosa and esophagus, the outer root sheath of hair follicles, and the glandular epithelia. This KRT6 gene in particular encodes the most abundant isoform. Mutations in these genes have been associated with pachyonychia congenita. In addition, peptides from the C-terminal region of the protein have antimicrobial activity against bacterial pathogens. The type II cytokeratins are clustered in a region of chromosome 12q12-q13. [provided by RefSeq, Oct 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0057082474).
BP6
Variant 12-52487848-C-T is Benign according to our data. Variant chr12-52487848-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 773545.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-52487848-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00142 (216/152322) while in subpopulation AFR AF = 0.00402 (167/41560). AF 95% confidence interval is 0.00352. There are 1 homozygotes in GnomAd4. There are 103 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position FAILED quality control check.
BS2
High AC in GnomAd4 at 216 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KRT6ANM_005554.4 linkc.1567G>A p.Val523Ile missense_variant Exon 9 of 9 ENST00000330722.7 NP_005545.1 P02538A0A0S2Z428

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KRT6AENST00000330722.7 linkc.1567G>A p.Val523Ile missense_variant Exon 9 of 9 1 NM_005554.4 ENSP00000369317.3 P02538

Frequencies

GnomAD3 genomes
AF:
0.00142
AC:
216
AN:
152204
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00403
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000412
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000736
AC:
185
AN:
251250
AF XY:
0.000729
show subpopulations
Gnomad AFR exome
AF:
0.00389
Gnomad AMR exome
AF:
0.000781
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.000379
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000696
AC:
1017
AN:
1461674
Hom.:
1
Cov.:
35
AF XY:
0.000693
AC XY:
504
AN XY:
727140
show subpopulations
Gnomad4 AFR exome
AF:
0.00451
AC:
151
AN:
33472
Gnomad4 AMR exome
AF:
0.000738
AC:
33
AN:
44716
Gnomad4 ASJ exome
AF:
0.00
AC:
0
AN:
26132
Gnomad4 EAS exome
AF:
0.000151
AC:
6
AN:
39698
Gnomad4 SAS exome
AF:
0.00144
AC:
124
AN:
86244
Gnomad4 FIN exome
AF:
0.000131
AC:
7
AN:
53420
Gnomad4 NFE exome
AF:
0.000575
AC:
639
AN:
1111854
Gnomad4 Remaining exome
AF:
0.000861
AC:
52
AN:
60376
Heterozygous variant carriers
0
56
112
167
223
279
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00142
AC:
216
AN:
152322
Hom.:
1
Cov.:
33
AF XY:
0.00138
AC XY:
103
AN XY:
74478
show subpopulations
Gnomad4 AFR
AF:
0.00402
AC:
0.00401829
AN:
0.00401829
Gnomad4 AMR
AF:
0.000588
AC:
0.000587851
AN:
0.000587851
Gnomad4 ASJ
AF:
0.00
AC:
0
AN:
0
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.00145
AC:
0.00144928
AN:
0.00144928
Gnomad4 FIN
AF:
0.000188
AC:
0.000188182
AN:
0.000188182
Gnomad4 NFE
AF:
0.000412
AC:
0.000411607
AN:
0.000411607
Gnomad4 OTH
AF:
0.000473
AC:
0.000473037
AN:
0.000473037
Heterozygous variant carriers
0
12
24
37
49
61
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000763
Hom.:
4
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000778
AC:
3
ExAC
AF:
0.000700
AC:
85
EpiCase
AF:
0.000436
EpiControl
AF:
0.000296

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 04, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

KRT6A-related disorder Benign:1
May 27, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
12
DANN
Benign
0.72
DEOGEN2
Benign
0.11
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.014
N
LIST_S2
Benign
0.093
T
M_CAP
Benign
0.064
D
MetaRNN
Benign
0.0057
T
MetaSVM
Benign
-0.80
T
MutationAssessor
Benign
1.1
L
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
-0.080
N
REVEL
Benign
0.093
Sift
Benign
0.40
T
Sift4G
Benign
0.39
T
Polyphen
0.0
B
Vest4
0.078
MVP
0.32
MPC
0.23
ClinPred
0.0011
T
GERP RS
-1.0
Varity_R
0.026
gMVP
0.21
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs62617088; hg19: chr12-52881632; COSMIC: COSV58107450; COSMIC: COSV58107450; API